Investment-linked insurance products: complexity label a long time coming
THE recent news about the rising number of complaints against investment-linked insurance policies (ILPs) isn’t surprising. In 2024, complaints about ILPs filed with the Financial Industry Disputes Resolution Centre (Fidrec) reportedly hit a high of 211, up from 55 in 2023.
This year, 57 complaints were lodged in the first half-year.
ILP sales have surged since around 2022, overtaking traditional participating plans. The sale of ILPs, especially those sold in single-premium mode, tends to rise when markets are strong. But for a product as complex as an ILP, a rising risk appetite driven by fear of missing out and aggressive sales tactics by insurance representatives make a potent brew for mis-selling.
TRENDING NOW
Qatari LNG ship struck in Strait of Hormuz, testing US talks
DBS shares rise 1.9% to hit all-time intraday high as sentiment improves
‘Baptism of fire’: Andre Khor on leading Singapore refiner Aster through an energy crisis
Singapore retains top spot as most expensive city for HNWIs, with five Apac cities in global top 10